Emergent BioSolutions Inc...

NYSE: EBS · Real-Time Price · USD
8.85
0.03 (0.34%)
At close: Aug 15, 2025, 3:59 PM
8.82
-0.28%
After-hours: Aug 15, 2025, 07:40 PM EDT

Emergent BioSolutions Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
846.2M 960M 1.04B 1.13B 1.1B 1.19B 1.05B 1.1B 1.07B 978.5M 1.12B 1.51B 1.6B 1.76B 1.79B 1.65B 1.71B 1.71B
Cost of Revenue
336.1M 645.3M 717.8M 801.6M 848.8M 730.2M 724.3M 741.9M 713.7M 692.9M 693.7M 687.2M 756.1M 814.1M 757.5M 712.9M 644.4M 546.4M
Gross Profit
415.7M 303.4M 309.1M 323.9M 253.4M 455.2M 325.8M 362.3M 360M 285.6M 427.2M 826.2M 846.3M 943.1M 1.04B 939.6M 1.06B 1.16B
Operating Income
106.5M -54.2M -64.3M -96.7M -403.3M -537.1M -725M -741.5M -541.4M -320.5M -166M 169.8M 177.1M 263.6M 352.6M 333.3M 429.3M 540.8M
Interest Income
n/a n/a n/a 500K 500K 500K 500K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
190.7M -62.3M -142.9M -169.8M -578.1M -558.5M -731.7M -748.4M -546.4M -379M -221.7M 117M 135.4M 225.4M 314.4M 299.7M 400.2M 513.7M
Net Income
139.5M -131.6M -190.6M -208.8M -589.5M -567.7M -759.7M -798.2M -608M -403.1M -223.8M 53.5M 96.5M 157.5M 230.9M 227M 299.2M 387.3M
Selling & General & Admin
233.5M 267.1M 299.3M 326M 335.4M 349.5M 365.4M 372.1M 366.3M 356M 340.3M 340.3M 342.2M 352.3M 348.4M 336.3M 329.7M 314.5M
Research & Development
50.5M 65.3M 65.2M 85.3M 86.8M 85.5M 111.1M 139.5M 163.4M 187.2M 193M 218.4M 228.8M 227.9M 234M 210.5M 245.3M 244.3M
Other Expenses
105.7M 22.6M 6.3M 6.3M -3.4M -7M 10M 27.9M 45.3M 45.9M 26.9M 8.1M -8.3M -4M -3.7M 600K 4.3M 4.1M
Operating Expenses
403.6M 368.9M 384.7M 420.6M 438.5M 467.4M 525.9M 578.9M 594.7M 606.1M 593.2M 614.7M 627.5M 637.8M 640.9M 606.3M 635M 618.7M
Interest Expense
23.1M 61.4M 71M 78.4M 89.8M 94.8M 88.4M 79M 67.8M 47M 37.3M 33.5M 33.4M 34.2M 34.5M 34.2M 33.4M 31.2M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -63.6M -63.6M -63.6M
Cost & Expenses
600.4M 1.01B 1.1B 1.22B 1.29B 1.2B 1.25B 1.32B 1.31B 1.3B 1.29B 1.3B 1.38B 1.45B 1.4B 1.32B 1.28B 1.17B
Income Tax Expense
51.2M 69.3M 47.7M 39M 27.7M 25.5M 44.3M 66.1M 61.6M 24.1M 2.1M 63.5M 38.9M 67.9M 83.5M 72.7M 101M 126.4M
Shares Outstanding (Basic)
54.2M 54.4M 54.2M 53.1M 52.6M 52.2M 51.9M 51.8M 50.7M 50.2M 49.9M 49.8M 49.91M 50.7M 53.2M 53.61M 53.6M 53.3M
Shares Outstanding (Diluted)
54.2M 57.3M 54.2M 55.6M 52.6M 52.2M 51.9M 51.8M 50.7M 50.2M 49.9M 49.9M 50M 50.7M 53.5M 53.7M 54M 54.5M
EPS (Basic)
2.60 -2.56 -3.64 -4 -11.29 -11.06 -14.88 -15.69 -12.08 -8.06 -4.48 0.82 1.73 2.95 4.33 4.30 5.66 7.33
EPS (Diluted)
2.44 -2.72 -3.74 -4.1 -11.29 -11.06 -14.88 -15.69 -12.08 -8.06 -4.48 0.78 1.69 2.91 4.26 4.20 5.54 7.18
EBITDA
324.7M 106.3M 38.7M 23.7M -367.4M -336.4M -507.8M -521.4M -349.4M -197.8M -54.9M 266.2M 302.5M 381.3M 468.4M 453.1M 551.3M 663.4M
EBIT
246.9M -900K -71.9M -91.9M -488.8M -464.2M -643.3M -668.9M -481.4M -334.8M -187.7M 145.7M 167.3M 258.1M 347.4M 333.9M 433.6M 544.9M
Depreciation & Amortization
77.8M 107.2M 110.6M 115.1M 117.8M 121.3M 127.1M 137.8M 141M 152.6M 148.9M 138.4M 138.8M 127.5M 125.3M 123.5M 119.6M 115M